
==== Front
EMBO J
EMBO J
The EMBO Journal
0261-4189
1460-2075
Nature Publishing Group UK London

39020148
170
10.1038/s44318-024-00170-w
News & Views
Wengen’s hidden powers: ROS triggers a TNFR-dependent tissue regenerative pathway in Drosophila
http://orcid.org/0000-0003-1209-6102
Andersen Ditte S ditte.andersen@bio.ku.dk

http://orcid.org/0000-0002-8250-4899
Colombani Julien julien.colombani@bio.ku.dk

https://ror.org/035b05819 grid.5254.6 0000 0001 0674 042X Department of Biology, University of Copenhagen, Universitetsparken 15, 2100 Copenhagen, Denmark
17 7 2024
17 7 2024
9 2024
43 17 35503552
1 7 2024
2 7 2024
© The Author(s) 2024
2024
https://creativecommons.org/licenses/by/4.0/ Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. Creative Commons Public Domain Dedication waiver http://creativecommons.org/publicdomain/zero/1.0/ applies to the data associated with this article, unless otherwise stated in a credit line to the data, but does not extend to the graphical or creative elements of illustrations, charts, or figures. This waiver removes legal barriers to the re-use and mining of research data. According to standard scholarly practice, it is recommended to provide appropriate citation and attribution whenever technically possible.
While the role of the Tumor necrosis factor-α (referred to as TNF here) as a key mediator of pro-inflammatory and immune responses is well-established, non-pathological functions of the TNF-TNF receptor (TNFR) signaling are less explored. In this issue of The EMBO Journal, Esteban-Collado et al, (2024) describe a TNF independent, pro-survival role of the Drosophila TNFR Wengen during damage-induced tissue regeneration.

Recent study identifies the Drosophila TNF receptor Wengen as a TNF-independent mediator of tissue regeneration in response to apoptosis.

Subject terms

Autophagy & Cell Death
Signal Transduction
http://dx.doi.org/10.13039/100010663 EC | H2020 | PRIORITY 'Excellent science' | H2020 European Research Council (ERC) 803630 http://dx.doi.org/10.13039/501100004191 Novo Nordisk (Novo Nordisk Global) NNF180C0033920 NNF20OC0065395 issue-copyright-statement© European Molecular Biology Organization 2024
==== Body
pmcTumor necrosis factor-α (referred to as TNF here) is the founding member of a large family of TNF-related factors that regulate diverse processes ranging from cell proliferation and apoptosis to innate and adaptive immunity. Due to its implication in promoting inflammatory pathologies, such as inflammatory bowel disease (IBD), obesity-related type 2 diabetes, and cancers, the pathological properties of TNF have been particularly well studied. On the other hand, surprisingly little is known about processes regulated by the TNF-TNFR network in non-pathological conditions. This is in part due to the functional redundancy and complexity of the mammalian TNF ligand-receptor network comprising 19 ligands and 29 related TNFRs, which represents a significant obstacle in uncovering the physiological processes mediated by the TNF-TNFR network (Patel and Patel 2017). The highly simplified Drosophila TNF-TNFR system, which consists of one TNF ligand, Eiger (Egr), and two TNFRs, Grindelwald (Grnd) and Wengen (Wgn), offers a powerful alternative for studying these functions and has recently been successful in uncovering important homeostasis promoting TNF/TNFR-dependent functions (Esteban-Collado et al, 2024, Letizia et al, 2023, Loudhaief et al, 2023, Colombani and Andersen 2023, Muliyil et al, 2020).

While Wgn was identified two decades ago based on a weak homology of its cysteine-rich domains (CRD) with other members of the TNFR superfamily and its association with Egr/TNF (Kauppila et al, 2003; Kanda et al, 2002), Grnd, which shares little sequence homology with other TNFRs, was identified much later through a functional approach (Andersen et al, 2015). Recent studies have shown that Grnd and Wgn are present in different subcellular compartments, implying that these receptors fulfill distinct and non-redundant roles in cellular function. While Grnd localizes to the membrane, Wgn is primarily found in intracellular vesicles, suggesting distinct activation mechanisms for these receptors. Indeed, ectopic expression of Egr/TNF in wing imaginal disks (precursors of the adult wing) triggers the internalization of Grnd and Egr into vesicles that are separate from Wgn-positive vesicles (Palmerini et al, 2021). Consistent with this, Grnd, but not Wgn, is required for Egr-induced apoptosis (Andersen et al, 2015).

The finding that the majority of Wgn is present in intracellular vesicles, and hence not accessible for binding with extracellular Egr, raises questions about the mechanism of Wgn activation. Possible scenarios include the re-localization of Wgn to the membrane in response to specific stimuli and/or Egr-independent receptor activation. In support of the latter, Ruan et al. reported that Wgn, but not Egr, is required for the targeting of photoreceptor axons to the medulla, providing an example of a physiological process where Wgn signals independently of Egr (Ruan et al, 2013). More recently, two studies found that Wgn resides in endocytic compartments in both the gut and the trachea (the equivalent of the mammalian vasculature), where it promotes Egr/TNF-independent processes through an effect on protein stability. In the adult gut, Wgn controls dTRAF3 stability to restrict lipid catabolism and promote tissue homeostasis (Loudhaief et al, 2023), while in the trachea, it regulates receptor tyrosine kinase (RTK) stability to ensure correct specification of tracheal terminal cells (Letizia et al, 2023). These studies suggest that Wgn mediates processes that goes beyond the well-established functions of TNF/TNFRs in apoptotic, inflammatory, and immune responses and raises questions regarding how Wgn might be activated and how downstream Wgn effectors relate to the canonical dTRAF2-dTAK1-JNK signaling module employed by Grnd.

In this issue, Esteban-Collado J. et al. provide compelling evidence supporting distinct and opposing functions of Grnd and Wgn in wing imaginal disks. They demonstrate that the Grnd-dTRAF2-dTAK1-JNK signaling pathway promotes apoptosis in an Egr-dependent manner, while the Wgn-dTRAF1-Ask1-p38 MAPK module promotes survival independently of Egr. They reveal distinct responses between Grnd, which is internalized from the plasma membrane upon Egr overexpression, and Wgn, whose cytoplasmic levels decrease in Egr overexpressing cells but become enriched in neighboring wild-type cells. The non-autonomous accumulation of Wgn requires ROS, but not Egr production, by dying cells. Finally, employing an elegant binary system that allows independent gene manipulation in specific domains of the tissue, the authors establish the essential role of Wgn, but not Grnd, in the regenerative response to apoptosis, mediated through the activation and phosphorylation of p38 MAPK. These findings support a model in which ROS from damaged tissue activates Wgn-dependent signaling in surrounding cells to promote tissue regeneration. The authors speculate that ROS-dependent oxidation of cysteine residues in the CRD of Wgn may trigger self-association and recruitment of dTRAF1 to promote ligand-independent signaling.

The major significance of this work is the characterization of the distinct behaviors of the two Drosophila TNFRs, centered around their pro-apoptotic or pro-survival properties. The study nicely complements recent findings (Letizia et al, 2023; Loudhaief et al, 2023; Palmerini et al, 2021). It expands our knowledge on processes controlled by TNFR-mediated signaling, highlighting the potential for ligand-independent regulation. The understanding of the mechanistic interplay between TNFR in integrating TNF-dependent and independent signals to stimulate distinct downstream responses lays the foundation for investigating whether these insights can be generalized to other members of the TNFR superfamily. Beyond its contribution to fundamental biology, the study has biomedical implications for regenerative medicine. It emphasizes the necessity of balancing TNFR activities, downstream signaling, and their dependence on ligands, providing important insights for the development of receptor agonists or antagonists.

Intriguingly, Wgn employs dTRAF2 to regulate JNK- and NF-kB-mediated effects on immunity, dTRAF3 to control lipid metabolism and tissue homeostasis, and dTRAF1 to promote Ask1-p38-mediated survival and regeneration (Fig. 1). Understanding how the activation of Wgn by different upstream signals is coupled with the recruitment of specific dTRAFs to elicit distinct cellular responses will be a fascinating direction of future research.Figure 1 The Drosophila TNF/TNFR signaling pathways.

The binding of the Egr/TNF to Grnd triggers an apoptotic response through the dTRAF2-JNK signaling pathway. In response to Egr-dependent and independent stimuli, Wgn associates with different dTRAFs to elicit distinct pro-survival responses.

Acknowledgements

Work in our lab is supported by H2020 European Research Council grant number 803630 and Novo Nordisk Foundation grant numbers NNF180C0033920 and NNF20OC0065395.

Disclosure and competing interests statement

The authors declare no competing interests.

See also: J Esteban-Collado et al

These authors contributed equally: Ditte S Andersen, Julien Colombani.
==== Refs
References

Andersen DS Colombani J Palmerini V Chakrabandhu K Boone E Röthlisberger M Toggweiler J Basler K Mapelli M Hueber AO Léopold P The Drosophila TNF receptor Grindelwald couples loss of cell polarity and neoplastic growth Nature 2015 522 7557 482 486 10.1038/nature14298 25874673
Andersen DS, Colombani J, Palmerini V, Chakrabandhu K, Boone E, Röthlisberger M, Toggweiler J, Basler K, Mapelli M, Hueber AO, Léopold P (2015) The Drosophila TNF receptor Grindelwald couples loss of cell polarity and neoplastic growth. Nature 522(7557):482–48625874673 10.1038/nature14298
Colombani J Andersen DS Drosophila TNF / TNFRS: At the crossroad between metabolism, immunity, and tissue homeostasis FEBS Lett 2023 597 19 2416 2432 10.1002/1873-3468.14716 37567762
Colombani J, Andersen DS (2023) Drosophila TNF / TNFRS: At the crossroad between metabolism, immunity, and tissue homeostasis. FEBS Lett 597(19):2416–243237567762 10.1002/1873-3468.14716
Esteban-Collado, J, Fernàndez-Mañas, M, Fernández-Moreno M, Maeso, I, Corominas M, Serras, F (2024) Reactive oxygen species activate the Drosophila TNF receptor Wengen for damage-induced regeneration. EMBO J. 10.1038/s44318-024-00155-9
Kanda H Igaki T Kanuka H Yagi T Miura M Wengen, a member of the Drosophila tumor necrosis factor receptor superfamily, is required for Eiger signaling J Biol Chem 2002 277 28372 28375 10.1074/jbc.C200324200 12084706
Kanda H, Igaki T, Kanuka H, Yagi T, Miura M (2002) Wengen, a member of the Drosophila tumor necrosis factor receptor superfamily, is required for Eiger signaling. J Biol Chem 277:28372–2837512084706 10.1074/jbc.C200324200
Kauppila S Maaty WS Chen P Tomar RS Eby MT Chapo J Chew S Rathore N Zachariah S Sinha SK Abrams JM Chaudhary PM Eiger and its receptor, Wengen, comprise a TNF-like system in Drosophila Oncogene 2003 22 4860 4867 10.1038/sj.onc.1206715 12894227
Kauppila S, Maaty WS, Chen P, Tomar RS, Eby MT, Chapo J, Chew S, Rathore N, Zachariah S, Sinha SK, Abrams JM, Chaudhary PM (2003) Eiger and its receptor, Wengen, comprise a TNF-like system in Drosophila. Oncogene 22:4860–486712894227 10.1038/sj.onc.1206715
Letizia A Espinàs ML Giannios P Llimargas M The TNFR Wengen regulates the FGF pathway by an unconventional mechanism Nat Commun 2023 14 1 5874 10.1038/s41467-023-41549-3 37735159
Letizia A, Espinàs ML, Giannios P, Llimargas M (2023) The TNFR Wengen regulates the FGF pathway by an unconventional mechanism. Nat Commun 14(1):587437735159 10.1038/s41467-023-41549-3
Loudhaief R Jneid R Christensen CF Mackay DJ Andersen DS Colombani J The Drosophila tumor necrosis factor receptor, Wengen, couples energy expenditure with gut immunity Sci Adv 2023 9 23 eadd4977 10.1126/sciadv.add4977 37294765
Loudhaief R, Jneid R, Christensen CF, Mackay DJ, Andersen DS, Colombani J (2023) The Drosophila tumor necrosis factor receptor, Wengen, couples energy expenditure with gut immunity. Sci Adv 9(23):eadd497737294765 10.1126/sciadv.add4977
Muliyil S Levet C Düsterhöft S Dulloo I Cowley SA Freeman M ADAM17-triggered TNF signalling protects the ageing Drosophila retina from lipid droplet-mediated degeneration EMBO J 2020 39 e104415 10.15252/embj.2020104415 32715522
Muliyil S, Levet C, Düsterhöft S, Dulloo I, Cowley SA, Freeman M (2020) ADAM17-triggered TNF signalling protects the ageing Drosophila retina from lipid droplet-mediated degeneration. EMBO J 39:e10441532715522 10.15252/embj.2020104415
Palmerini V Monzani S Laurichesse Q Loudhaief R Mari S Cecatiello V Olieric V Pasqualato S Colombani J Andersen DS Mapelli M Drosophila TNFRs Grindelwald and Wengen bind Eiger with different affinities and promote distinct cellular functions Nat Commun 2021 12 1 2070 10.1038/s41467-021-22080-9 33824334
Palmerini V, Monzani S, Laurichesse Q, Loudhaief R, Mari S, Cecatiello V, Olieric V, Pasqualato S, Colombani J, Andersen DS, Mapelli M (2021) Drosophila TNFRs Grindelwald and Wengen bind Eiger with different affinities and promote distinct cellular functions. Nat Commun 12(1):207033824334 10.1038/s41467-021-22080-9
Patel HJ Patel BM TNF-alpha and cancer cachexia: molecular insights and clinical implications Life Sci 2017 170 56 63 10.1016/j.lfs.2016.11.033 27919820
Patel HJ, Patel BM (2017) TNF-alpha and cancer cachexia: molecular insights and clinical implications. Life Sci 170:56–6327919820 10.1016/j.lfs.2016.11.033
Ruan W Unsain N Desbarats J Fon EA Barker PA Wengen, the sole tumour necrosis factor receptor in Drosophila, collaborates with moesin to control photoreceptor axon targeting during development PLoS ONE 2013 8 3 e60091 10.1371/journal.pone.0060091 23544124
Ruan W, Unsain N, Desbarats J, Fon EA, Barker PA (2013) Wengen, the sole tumour necrosis factor receptor in Drosophila, collaborates with moesin to control photoreceptor axon targeting during development. PLoS ONE 8(3):e6009123544124 10.1371/journal.pone.0060091
